We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Europe Allows Sale of Genetically Modified Corn

By Biotechdaily staff writers
Posted on 25 May 2004
Despite reservations on the part of many of the member states, the European Commission has announced it will allow the sale of Bt-11 sweet corn, thereby ending a six-year moratorium on the import of genetically modified (GM) food products. More...
The ruling will allow the import of Bt-11 corn already canned and ready for the supermarket shelf. Members of the European Union (EU) will not be allowed to cultivate Bt-11 sweet corn.

Bt-11 sweet corn was developed by Syngenta (Basel, Switzerland). Normal maize (Zea mays) was modified by the insertion of a gene from the bacterium Bacillus thuringiensis that produces the Bt protein Cry1Ab. When eaten by the European corn borer or corn earworm, two important sweet corn pests, digestive enzymes in the alkaline environment of the larva's intestine metabolize Cry1Ab, yielding a shorter protein that binds to the wall of the intestine. Following binding, pores are formed that disrupt midgut ion flow, causing gut paralysis and eventual death from bacterial sepsis. Cry1Ab is lethal only when eaten by the larvae of lepidopteran insects (moths and butterflies), and its specificity of action is directly attributable to the presence of specific binding sites in the target insects. There are no binding sites for the delta-endotoxins of B thuringiensis on the surface of mammalian intestinal cells. Therefore, livestock animals and humans are not susceptible to these proteins.

The safety of Bt-11 sweet corn for use as a food has been demonstrated by digestibility studies, toxicity studies, and allergenicity studies. The composition and nutritional value of Bt-11 has been shown to be comparable or substantially equivalent to non-Bt sweet corn. Objection to the use of GM corn is based primarily on anecdotal reports such as those of livestock dying of "mysterious” illnesses after having been fed genetically modified maize. Other concerns center on the genetic stability of the modified plants and on the activity of the Bt genes as they move up the food chain.

While the World Health Organization (WHO, Geneva, Switzerland) is strongly promoting GM foods as the key to preventing food shortages in the coming decades, the success of GM foods in Europe will largely be determined by the willingness of consumers to buy them.




Related Links:
Syngenta

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
HPV Test
Allplex HPV28 Detection
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.